131 related articles for article (PubMed ID: 38556106)
21. Autocrine/Paracrine Loop Between SCF
Annese T; Tamma R; Bozza M; Zito A; Ribatti D
Front Immunol; 2022; 13():794974. PubMed ID: 35140718
[TBL] [Abstract][Full Text] [Related]
22. Human intestinal fibroblasts prevent apoptosis in human intestinal mast cells by a mechanism independent of stem cell factor, IL-3, IL-4, and nerve growth factor.
Sellge G; Lorentz A; Gebhardt T; Levi-Schaffer F; Bektas H; Manns MP; Schuppan D; Bischoff SC
J Immunol; 2004 Jan; 172(1):260-7. PubMed ID: 14688333
[TBL] [Abstract][Full Text] [Related]
23. The pathogenic role of c-Kit+ mast cells in the spinal motor neuron-vascular niche in ALS.
Kovacs M; Alamón C; Maciel C; Varela V; Ibarburu S; Tarragó L; King PH; Si Y; Kwon Y; Hermine O; Barbeito L; Trias E
Acta Neuropathol Commun; 2021 Aug; 9(1):136. PubMed ID: 34389060
[TBL] [Abstract][Full Text] [Related]
24. Impact of triple negative phenotype on breast cancer prognosis.
Kaplan HG; Malmgren JA
Breast J; 2008; 14(5):456-63. PubMed ID: 18657139
[TBL] [Abstract][Full Text] [Related]
25. Differentiation of fetal hematopoietic stem cells requires ARID4B to restrict autocrine KITLG/KIT-Src signaling.
Young IC; Wu B; Andricovich J; Chuang ST; Li R; Tzatsos A; Wu RC; Wu MY
Cell Rep; 2021 Nov; 37(8):110036. PubMed ID: 34818550
[TBL] [Abstract][Full Text] [Related]
26. 5-azacytidine and decitabine exert proapoptotic effects on neoplastic mast cells: role of FAS-demethylation and FAS re-expression, and synergism with FAS-ligand.
Ghanim V; Herrmann H; Heller G; Peter B; Hadzijusufovic E; Blatt K; Schuch K; Cerny-Reiterer S; Mirkina I; Karlic H; Pickl WF; Zöchbauer-Müller S; Valent P
Blood; 2012 May; 119(18):4242-52. PubMed ID: 22438247
[TBL] [Abstract][Full Text] [Related]
27. CREBZF mRNA nanoparticles suppress breast cancer progression through a positive feedback loop boosted by circPAPD4.
Zhou B; Xue J; Wu R; Meng H; Li R; Mo Z; Zhai H; Chen X; Liu R; Lai G; Chen X; Li T; Zheng S
J Exp Clin Cancer Res; 2023 Jun; 42(1):138. PubMed ID: 37264406
[TBL] [Abstract][Full Text] [Related]
28. Estrogen receptor 1 and progesterone receptor are distinct biomarkers and prognostic factors in estrogen receptor-positive breast cancer: Evidence from a bioinformatic analysis.
Wu JR; Zhao Y; Zhou XP; Qin X
Biomed Pharmacother; 2020 Jan; 121():109647. PubMed ID: 31733575
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of hepatic stem cell factor by Vivo-Morpholino treatment inhibits mast cell migration and decreases biliary damage/senescence and liver fibrosis in Mdr2
Meadows V; Kennedy L; Hargrove L; Demieville J; Meng F; Virani S; Reinhart E; Kyritsi K; Invernizzi P; Yang Z; Wu N; Liangpunsakul S; Alpini G; Francis H
Biochim Biophys Acta Mol Basis Dis; 2019 Dec; 1865(12):165557. PubMed ID: 31521820
[TBL] [Abstract][Full Text] [Related]
30. Effect of continuous statistically standardized measures of estrogen and progesterone receptors on disease-free survival in NCIC CTG MA.12 Trial and BC Cohort.
Chapman JA; Nielsen TO; Ellis MJ; Bernard P; Chia S; Gelmon KA; Pritchard KI; Le Maitre A; Goss PE; Leung S; Shepherd LE; Bramwell VH
Breast Cancer Res; 2013; 15(4):R71. PubMed ID: 23972025
[TBL] [Abstract][Full Text] [Related]
31. Crosstalk between Tumor-Infiltrating Immune Cells and Cancer-Associated Fibroblasts in Tumor Growth and Immunosuppression of Breast Cancer.
Soongsathitanon J; Jamjuntra P; Sumransub N; Yangngam S; De la Fuente M; Landskron G; Thuwajit P; Hermoso MA; Thuwajit C
J Immunol Res; 2021; 2021():8840066. PubMed ID: 34337083
[TBL] [Abstract][Full Text] [Related]
32. Mast cells modulate proliferation, migration and stemness of glioma cells through downregulation of GSK3β expression and inhibition of STAT3 activation.
Attarha S; Roy A; Westermark B; Tchougounova E
Cell Signal; 2017 Sep; 37():81-92. PubMed ID: 28600192
[TBL] [Abstract][Full Text] [Related]
33. Transformation of primary murine peritoneal mast cells by constitutive KIT activation is accompanied by loss of
Capellmann S; Sonntag R; Schüler H; Meurer SK; Gan L; Kauffmann M; Horn K; Königs-Werner H; Weiskirchen R; Liedtke C; Huber M
Front Immunol; 2023; 14():1154416. PubMed ID: 37063827
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic histone modification by butyrate downregulates KIT and attenuates mast cell function.
Gudneppanavar R; Sabu Kattuman EE; Teegala LR; Southard E; Tummala R; Joe B; Thodeti CK; Paruchuri S
J Cell Mol Med; 2023 Oct; 27(19):2983-2994. PubMed ID: 37603611
[TBL] [Abstract][Full Text] [Related]
35. The p53-dependent apoptotic pathway of breast cancer cells (BC-M1) induced by the bis-type bioreductive compound aziridinylnaphthoquinone.
Yang YP; Kuo HS; Tsai HD; Peng YC; Lin YL
Breast Cancer Res; 2005; 7(1):R19-27. PubMed ID: 15642166
[TBL] [Abstract][Full Text] [Related]
36. Membrane-bound stem cell factor is the major but not only driver of fibroblast-induced murine skin mast cell differentiation.
Leist M; Sünder CA; Drube S; Zimmermann C; Geldmacher A; Metz M; Dudeck A; Maurer M
Exp Dermatol; 2017 Mar; 26(3):255-262. PubMed ID: 27619074
[TBL] [Abstract][Full Text] [Related]
37. The Mast Cell-SCF-CB1 Interaction Is a Key Player in Seborrheic Keratosis.
Yamanaka-Takaichi M; Sugawara K; Sumitomo R; Tsuruta D
J Histochem Cytochem; 2020 Jul; 68(7):461-471. PubMed ID: 32578480
[TBL] [Abstract][Full Text] [Related]
38. Role of stem cell factor and mast cells in the progression of chronic glomerulonephritides.
El-Koraie AF; Baddour NM; Adam AG; El Kashef EH; El Nahas AM
Kidney Int; 2001 Jul; 60(1):167-72. PubMed ID: 11422748
[TBL] [Abstract][Full Text] [Related]
39. CREB Is Indispensable to KIT Function in Human Skin Mast Cells-A Positive Feedback Loop between CREB and KIT Orchestrates Skin Mast Cell Fate.
Bal G; Schneikert J; Li Z; Franke K; Tripathi SR; Zuberbier T; Babina M
Cells; 2023 Dec; 13(1):. PubMed ID: 38201246
[TBL] [Abstract][Full Text] [Related]
40. Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated Remodeling.
Hamel KM; King CT; Cavalier MB; Liimatta KQ; Rozanski GL; King TA; Lam M; Bingham GC; Byrne CE; Xing D; Collins-Burow BM; Burow ME; Belgodere JA; Bratton MR; Bunnell BA; Martin EC
Stem Cells Dev; 2022 Oct; 31(19-20):604-620. PubMed ID: 35579936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
